Safety

EMA calls for action to address EU shortage of GLP-1 receptor agonists

The EMA and the Heads of the Medicines Agencies (HMA), through the Medicines Shortages and Safety Executive Steering Group (MSSG),…

1 week ago

Muñaro, a new drug for diabetes and obesity, arrived in Spain

Muñaro (tirzepatide), Lilly's drug for the treatment of type 2 diabetes (T2D) or for weight control in obese people, is…

1 week ago

Gilead Announces Full Effectiveness of Six-Year Subcutaneous Lenacapavir in HIV Prevention

Gilead presented results from the third phase of the Purpose 1 clinical trial, which assessed the effectiveness of a six-month…

2 weeks ago

Toyota apologizes and admits flaws in its safety certifications

Japanese carmaker Toyota has apologized to customers and admitted that seven models in its lineup suffered safety test violations as…

1 month ago

The ‘post-Covid era’ offers a promising future for new vaccine development

Vaccination interventions are expanding to new diseases and target populations; In addition, vaccines are easier and faster to produce, more…

5 months ago

Obesity: Drug treatment only works with lifestyle changes

In the current obesity-promoting environment, obesity prevention requires "a population-based and community-based approach with policies that facilitate access to healthy…

6 months ago